Lupin launches Generic Ortho Tri-Cyclen Lo Tablets
07 January 2016 | News | By BioSpectrum Bureau
Lupin launches Generic Ortho Tri-Cyclen Lo Tablets
Lupins's tablets are are the AB rated generic equivalent of Janssen Pharmaceutical's Ortho Tri-Cyclen Lo Tablets
Pharma Major Lupin has announced that its US subsidiary Lupin Pharmaceutical Inc. has launched its Tri-Lo-Marzia Tablets (Norgestimate and Ethinyl Estradiol Tablets USP, 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg) having received approval from the United States Food and Drug Administration (FDA).
Lupin's Tri-Lo-Marzia Tablets (Norgestimate and Ethinyl Estradiol Tablets USP, 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg) are the AB rated generic equivalent of Janssen Pharmaceutical's Ortho Tri-Cyclen Lo Tablets, (Norgestimate and Ethinyl Estradiol Tablets USP, 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg). It is indicated for use by women to prevent pregnancy.
Ortho Tri-Cyclen Lo Tablets had US sales of $488.4 million (IMS MAT September 2015).
